With its P2X3 multi-indication program, Bayer highlighted another important candidate in mid-stage development. At Bayer, the promise of P2X3 antagonists was first identified for endometriosis. Endometriosis is a clinical condition affecting approximately 10 percent of women in reproductive age, many of whom experience severe chronic pain with debilitating effects on their professional, personal and social lives. P2X3 also has a prominent role in several other medical conditions associated with pain and neurogenic hypersensitivity such as chronic cough, overactive bladder and neuropathic pain. … [Read more...] about Bayer transforms pharma business through breakthrough innovation in healthcare
Redesign the it operating model to accelerate digital business
“Looking ahead, a combination of a strong pipeline and good order booking gives us a lot of optimism about the growth trajectory. I strongly believe that we are uniquely differentiated through a combination of solutions and services,” Mr. Vijayakumar said. … [Read more...] about HCL Tech Q3 profit rises 31% on digital, cloud momentum
However, again from the point of view of the Budget, this decline to Rs 195 lakh crore will help in projecting a number of 15 per cent growth in nominal terms (10 per cent real and 5 per cent inflation) which will bring the level to Rs 224 lakh cr which is what was projected for FY21. … [Read more...] about Economy to bounce back next year!
Pang Xiaogang, executive vice-president of State Grid, said the company, which offers services to over 1.1 billion people across 26 regions, built 172,000 charging piles by the end of 2020. It has come up with a fast charging network that covers 176 cities and 50,000 kilometers of highways nationwide. State-owned enterprises play an important role in boosting the modernization and stability of industrial and supply chains in the country, he said. … [Read more...] about State Grid unit forms JV with CSCEC
Thomas Hudson, senior vice-president of R&D and chief scientific officer, AbbVie, said in a statement that his company has been impressed with what I-Mab has been able to accomplish in research and clinical development and looks forward to working together to make a meaningful difference to the lives of millions of patients globally. … [Read more...] about Filling gaps in drug development